Ask AI
H.R. 1660Became Law

Global Health Innovation Act of 2017

Global Health Innovation Act of 2017

This bill directs the U.S. Agency for International Development (USAID) to report to Congress, annually for four years, on the development and use of global health innovations in USAID programs, projects, and activities.

Such reports shall include topics including: (1) USAID's health product development goals and progress towards their achievement; (2) how innovation has advanced USAID's commitments to achieving an HIV/AIDS-free generation, ending preventable child and maternal deaths, and protecting communities from infectious diseases; (3) how USAID, alone and in partnerships, is leveraging U.S. investments to achieve greater health innovation; and (4) coordination with other federal departments.

Became Public Law No: 115-411.

Rep. Sires, Albio [D-NJ-8](D-NJ)Sponsor
19 cosponsors11 D8 R
19cosponsors2committees27actions16subjects
  1. President

    Became Public Law No: 115-411.

  2. BecameLaw36000

    Became Public Law No: 115-411.

  3. President

    Signed by President.

  4. BecameLaw36000

    Signed by President.

  5. Floor

    Presented to President.

  6. President28000

    Presented to President.

  7. Floor

    Message on Senate action sent to the House.

  8. Floor

    Passed Senate without amendment by Unanimous Consent. (consideration: CR S8002)

  9. Floor17000

    Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR S8002)

  10. Calendars

    Placed on Senate Legislative Calendar under General Orders. Calendar No. 364.

  11. Committee

    Committee on Foreign Relations. Reported by Senator Corker without amendment. Without written report.

    Foreign Relations Committee
  12. Committee14000

    Committee on Foreign Relations. Reported by Senator Corker without amendment. Without written report.

    Foreign Relations Committee
  13. Committee

    Committee on Foreign Relations. Ordered to be reported without amendment favorably.

    Foreign Relations Committee
  14. IntroReferral

    Received in the Senate and Read twice and referred to the Committee on Foreign Relations.

    Foreign Relations Committee
  15. FloorH38310

    Motion to reconsider laid on the table Agreed to without objection.

  16. FloorH37300

    On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 423 - 3 (Roll no. 34). (text: CR 1/17/2018 H439)

  17. Floor8000

    Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 423 - 3 (Roll no. 34).(text: CR 1/17/2018 H439)

  18. FloorH30000

    Considered as unfinished business. (consideration: CR H538-539)

  19. FloorH37220

    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

  20. FloorH8D000

    DEBATE - The House proceeded with forty minutes of debate on H.R. 1660.

  21. FloorH30000

    Considered under suspension of the rules. (consideration: CR H439-440)

  22. FloorH30300

    Mr. Royce (CA) moved to suspend the rules and pass the bill.

  23. Committee

    Committee Consideration and Mark-up Session Held.

    Foreign Affairs Committee
  24. Committee

    Ordered to be Reported by Voice Vote.

    Foreign Affairs Committee
  25. IntroReferralH11100

    Referred to the House Committee on Foreign Affairs.

    Foreign Affairs Committee
  26. IntroReferralIntro-H

    Introduced in House

  27. IntroReferral1000

    Introduced in House

Jan 3, 201949

Global Health Innovation Act of 2017

This bill directs the U.S. Agency for International Development (USAID) to report to Congress, annually for four years, on the development and use of global health innovations in USAID programs, projects, and activities.

Such reports shall include topics including: (1) USAID's health product development goals and progress towards their achievement; (2) how innovation has advanced USAID's commitments to achieving an HIV/AIDS-free generation, ending preventable child and maternal deaths, and protecting communities from infectious diseases; (3) how USAID, alone and in partnerships, is leveraging U.S. investments to achieve greater health innovation; and (4) coordination with other federal departments.

Mar 22, 201880

Global Health Innovation Act of 2017

(Sec. 2) This bill directs the Administrator of the U.S. Agency for International Development (USAID) to report to Congress, annually for four years, on the development and use of global health innovations in USAID programs, projects, and activities.

Such reports shall include descriptions of: (1) goals and progress towards their achievement; (2) how innovation has advanced USAID's commitments to achieving an HIV/AIDS-free generation, ending preventable child and maternal deaths, and protecting communities from infectious diseases; (3) how USAID, alone and in partnerships, is leveraging U.S. investments to achieve greater health innovation; and (4) coordination with other federal departments.

Jan 18, 201881

(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)

Global Health Innovation Act of 2017

(Sec. 2) This bill directs the Administrator of the U.S. Agency for International Development (USAID) to report to Congress, annually for four years, on the development and use of global health innovations in USAID programs, projects, and activities.

Such reports shall include descriptions of: (1) goals and progress towards their achievement; (2) how innovation has advanced USAID's commitments to achieving an HIV/AIDS-free generation, ending preventable child and maternal deaths, and protecting communities from infectious diseases; (3) how USAID, alone and in partnerships, is leveraging U.S. investments to achieve greater health innovation; and (4) coordination with other federal departments.

Mar 21, 2017

Global Health Innovation Act of 2017

This bill directs the Administrator of the U.S. Agency for International Development (USAID) to report to Congress, annually for four years, on the development and use of global health innovations in USAID programs, projects, and activities.

Global Health Innovation Act of 2017 — Informed